Form 483

Mylan Laboratories Limited Form 483, 2017-04-18

FDA issued a Form 483 to Mylan Laboratories Limited on 2017-04-18 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Mylan Laboratories Limited · Bangalore, India · Issued April 18, 2017

Overview

  • 6 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Apr 2017
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Saleem A Akhtar, Scott T Ballard

18 Apr 2017
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Saleem A Akhtar, Scott T Ballard

18 Apr 2017
21 CFR 211.198(a)

Procedures to be written and followed

Cited by Saleem A Akhtar, Scott T Ballard

18 Apr 2017
21 CFR 211.198(a)

Procedures to be written and followed

Cited by Saleem A Akhtar, Scott T Ballard

18 Apr 2017
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Saleem A Akhtar, Scott T Ballard

Inspected site

MLMylan Laboratories LimitedBangalore, India

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)Cited across public-safe Form 483 observations2x
21 CFR 211.198(a)Cited across public-safe Form 483 observations2x
21 CFR 211.67(a)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 6 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere